LSE:AZN
LSE:AZNPharmaceuticals

Is AstraZeneca (LSE:AZN) Pricing Reflect Long Term Prospects After Strong Five Year Run

If you are wondering whether AstraZeneca shares are offering fair value at current levels, this article walks through what the numbers actually say about the stock. With the share price at £142.16 and returns of 4.6% over 7 days, 5.2% over 30 days, 4.6% year to date, 32.3% over 1 year, 30.0% over 3 years and 110.0% over 5 years, recent performance gives important context for any view on value. Recent headlines around AstraZeneca have kept the company firmly on investors' radars, including...
LSE:RIO
LSE:RIOMetals and Mining

Evaluating Rio Tinto Group (LSE:RIO) After Recent Share Price Strength And Conflicting Valuation Signals

Rio Tinto Group (LSE:RIO) is back on investors’ radar after recent share price moves. The stock closed at £60.06 as the miner’s long term returns and current fundamentals draw closer attention. See our latest analysis for Rio Tinto Group. While the latest 1 day share price return of 3.04% puts short term pressure on the stock, the 30 day share price return of 7.12% and 1 year total shareholder return of 32.38% indicate that momentum has been building rather than fading. If Rio Tinto has...
LSE:GLEN
LSE:GLENMetals and Mining

Glencore (LSE:GLEN) Valuation Checked After Recent Share Price Strength And Mixed Long Term Returns

Recent moves in Glencore (LSE:GLEN) have caught investor attention after a period of strong share price performance over the past 3 months and 1 year, prompting fresh questions about how its current valuation stacks up. See our latest analysis for Glencore. The £4.53 share price comes after a strong 30-day share price return of 18.99% and a 90-day share price return of 30.88%. The 1-year total shareholder return of 29.80% contrasts with a slightly negative 3-year total shareholder return and...